RIMINI vs. OSAKA: Insights on Kidney Transplant Rejection Rates
In the domain of kidney transplantation, BPAR, which stands for Biopsy-Proven Acute Rejection , is an essential issue that has to be addressed and prevented. Modern pilot researches, which include the RIMINI and OSAKA trials, highlight certain distinctive characteristics of various immunosuppressive protocols. In the RIMINI study group BPAR was much higher 22% and in the historical cohort the rate was unspecified. However, information concerning the immunosuppressants utilized in the historical data remains limited, which in turn poses a challenge to making pertinent comparisons. On the other hand, the OSAKA study which used Tac , MMF and steroids presented a BPAR of between 10-16%. Such contrast of situations suggests that there may be advantages in applying the specific combination of a drugs which was used in the experiment of OSAKA. The consequences in the RIMINI study were unfavorable; there was graft loss and five more cases of BPAR associated with poor graft function. This ...